Ottaviani G, Jaffe N (2009) The epidemiology of osteosarcoma. Cancer Treat Res 152:3–13. https://doi.org/10.1007/978-1-4419-0284-9_1
Longhi A, Pasini A, Cicognani A, Baronio F, Pellacani A, Baldini N, Bacci G (2005) Height as a risk factor for osteosarcoma. J Pediatr Hematol Oncol 27(6):314–318. https://doi.org/10.1097/01.MPH.0000169251.57611.8E
Musselman JRB, Bergemann TL, Ross JA, Sklar C, Silverstein KAT, Langer EK, Savage SA, Nagarajan R, Krailo M, Malkin D, Spector LG (2012) Case-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a children’s oncology group (COG) study. Int J Mol Epidemiol Genet 3(4):286
PubMed PubMed Central CAS Google Scholar
Troisi R, Masters MN, Joshipura K, Douglass C, Cole BF, Hoover RN, Simon MA, Gebhardt MC, Scarborough MT, Gitelis S, Eckardt JJ, Neff JR, Joyce MJ, Malawer M, McGuire M, Anderson HC (2006) Perinatal factors, growth and development, and osteosarcoma risk. Br J Cancer 95(11):1603. https://doi.org/10.1038/SJ.BJC.6603474
Article PubMed PubMed Central CAS Google Scholar
Arora RS, Kontopantelis E, Alston RD, Eden TO, Geraci M, Birch JM (2011) Relationship between height at diagnosis and bone tumours in young people: a meta-analysis. Cancer Causes Control 22(5):681–688. https://doi.org/10.1007/S10552-011-9740-9
Tjalma RA (1966) Canine bone sarcoma: estimation of relative risk as a function of body size. JNCI J Nat Cancer Inst 36(6):1137–1150. https://doi.org/10.1093/JNCI/36.6.1137
Article PubMed CAS Google Scholar
Cotterill SJ, Wright CM, Pearce MS, Craft AW (2004) Stature of young people with malignant bone tumors. Pediatr Blood Cancer 42(1):59–63. https://doi.org/10.1002/PBC.10437
Potter LR, Abbey-Hosch S, Dickey DM (2006) Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27(1):47–72. https://doi.org/10.1210/ER.2005-0014
Article PubMed CAS Google Scholar
Tamura N, Garbers DL (2003) Regulation of the guanylyl cyclase-B receptor by alternative splicing. J Biol Chem 278(49):48880–48889. https://doi.org/10.1074/JBC.M308680200
Article PubMed CAS Google Scholar
Karaca C, Bektas M, Dincer MT, Bakkaloglu OK, Cebeci Z, Bakir A, Seyahi N, Trabulus S, Tukek T (2023) NT-proCNP levels predict higher atherosclerotic cardiovascular risk profile in patients with proliferative diabetic retinopathy. Acta Diabetol 60(8):1027–1036. https://doi.org/10.1007/S00592-023-02095-Y/FIGURES/4
Article PubMed CAS Google Scholar
Olney RC (2006) C-type natriuretic peptide in growth: a new paradigm. Growth Hormone IGF Res 16:6–14. https://doi.org/10.1016/J.GHIR.2006.03.016
Espiner EA, Prickett TCR, Taylor RS, Reid RA, McCowan LM (2015) Effects of pre-eclampsia and fetal growth restriction on C-type natriuretic peptide. BJOG 122(9):1236–1243. https://doi.org/10.1111/1471-0528.13397
Article PubMed CAS Google Scholar
Alan T, Tufan AC (2008) C-type natriuretic peptide regulation of limb mesenchymal chondrogenesis is accompanied by altered N-cadherin and collagen type X-related functions. J Cell Biochem 105(1):227–235. https://doi.org/10.1002/JCB.21815
Article PubMed CAS Google Scholar
Babadagli ME, Tezcan B, Yilmaz ST, Tufan AC (2014) Matrilin-3 as a putative effector of C-type natriuretic peptide signaling during TGF-β induced chondrogenic differentiation of mesenchymal stem cells. Mol Biol Rep 41(9):5549–5555. https://doi.org/10.1007/S11033-014-3448-3
Article PubMed CAS Google Scholar
Bartels CF, Bükülmez H, Padayatti P, Rhee DK, Van Ravenswaaij-Arts C, Pauli RM, Mundlos S, Chitayat D, Shih LY, Al-Gazali LI, Kant S, Cole T, Morton J, Cormier-Daire V, Faivre L, Lees M, Kirk J, Mortier GR, Leroy J, Zabel B, Kim CA, Crow Y, Braverman NE, Van Den Akker F, Warman ML (2004) Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am J Hum Genet 75(1):27–34. https://doi.org/10.1086/422013
Article PubMed PubMed Central CAS Google Scholar
Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Y, Itoh H, Tanaka K, Saito Y, Katsuki M, Nakao K (2001) Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci U S A 98(7):4016–4021. https://doi.org/10.1073/PNAS.071389098
Article PubMed PubMed Central CAS Google Scholar
Del Ry S, Cantinotti M, Cabiati M, Caselli C, Storti S, Prescimone T, Murzi B, Clerico A, Giannessi D (2012) Plasma C-type natriuretic peptide levels in healthy children. Peptides (NY) 33(1):83–86. https://doi.org/10.1016/J.PEPTIDES.2011.11.005
Kocamaz E, Gok D, Cetinkaya A, Tufan AC (2012) Implication of C-type natriuretic peptide-3 signaling in glycosaminoglycan synthesis and chondrocyte hypertrophy during TGF-β1 induced chondrogenic differentiation of chicken bone marrow-derived mesenchymal stem cells. J Mol Histol 43(5):497–508. https://doi.org/10.1007/S10735-012-9430-2
Article PubMed CAS Google Scholar
Olney RC, Permuy JW, Prickett TCR, Han JC, Espiner EA (2012) Amino-terminal propeptide of C-type natriuretic peptide (NTproCNP) predicts height velocity in healthy children. Clin Endocrinol (Oxf) 77(3):416. https://doi.org/10.1111/J.1365-2265.2012.04392.X
Article PubMed CAS Google Scholar
Prickett TCR, Lynn AM, Barrell GK, Darlow BA, Cameron VA, Espiner EA, Richards AM, Yandle TG (2005) Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth. Pediatr Res 58(2):334–340. https://doi.org/10.1203/01.PDR.0000169964.66260.4B
Article PubMed CAS Google Scholar
Serkant Unal M, Cevik Tufan A (2016) Mesenchymal stem cells and C-type natriuretic peptide signaling: a proposal for a new treatment approach for skeletal dysplasias. Curr Stem Cell Res Ther 11(6):513–521. https://doi.org/10.2174/1574888X10666150202145939
Tamura N, Doolittle LK, Hammer RE, Shelton JM, Richardson JA, Garbers DL (2004) Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc Natl Acad Sci U S A 101(49):17300–17305. https://doi.org/10.1073/PNAS.0407894101
Article PubMed PubMed Central CAS Google Scholar
Tezcan B, Serter S, Kiter E, Tufan AC (2010) Dose dependent effect of C-type natriuretic peptide signaling in glycosaminoglycan synthesis during TGF-β1 induced chondrogenic differentiation of mesenchymal stem cells. J Mol Histol 41(4–5):247–258. https://doi.org/10.1007/S10735-010-9284-4
Article PubMed CAS Google Scholar
Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, Kurihara T, Rogi T, Tanaka S, Suda M, Tamura N, Ogawa Y, Nakao K (2004) Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 10(1):80–86. https://doi.org/10.1038/NM971
Article PubMed CAS Google Scholar
Borinstein SC, Barkauskas DA, Bernstein M, Goorin A, Gorlick R, Krailo M, Schwartz CL, Wexler LH, Toretsky JA (2014) Analysis of serum ınsulin growth factor-1 concentrations in localized osteosarcoma: a children’s oncology group study. Pediatr Blood Cancer 61(4):749. https://doi.org/10.1002/PBC.24778
Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, Hoover RN, Chanock SJ, Simon MA, Gebhardt MC, Scarborough MT, Gitelis S, Eckardt JJ, Neff JR, Joyce MJ, Malawer M, McGuire M, Anderson HC (2007) Analysis of genes critical for growth regulation identifies ınsulin-like growth factor 2 receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 16(8):1667–1674. https://doi.org/10.1158/1055-9965.EPI-07-0214
Article PubMed CAS Google Scholar
Wang YH, Han XD, Qiu Y, Xiong J, Yu Y, Wang B, Zhu ZZ, Qian BP, Chen YX, Wang SF, Shi HF, Sun X (2012) Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma. J Surg Oncol 105(3):235–243. https://doi.org/10.1002/JSO.22077
留言 (0)